NEWS
Our Latest News
ARCHIMED Pharma Services announces the spin-off of portfolio company Suanfarma’s subsidiary, SuanNutra
The corporate carve-out is part of Suanfarma’s strategy to aggressively build its core business in the active pharmaceutical ingredient market. SuanNutra, which accounts for approximately a quarter of Suanfarma’s sales, is a scalable, globally recognized leader in the nutraceutical ingredients sector.
ARCHIMED buys Denmark’s DermaPharm A/S, a leading developer and manufacturer of skincare products
October
15,
2025
ARCHIMED acquires cell line development pioneer ExcellGene to accelerate expansion into biosimilars and high-performance transfection solutions
September
25,
2025
ARCHIMED acquires generative AI Diagnostics player Arkstone to support fight against infectious disease
August
1,
2025
ARCHIMED’s MED II sells DIESSE, returning 4.6x to shareholders
January
27,
2025
368